Abstract
Hematopoietic stem cell transplant (HSCT) began in humans in the late 1950s and since that time more than 800,000 people have been treated with this procedure. To date 150,000 patients are living 5 years or more post transplant, with this number expanding rapidly [1]. As advances have been made in refining HSCT and making it more accessible, a larger proportion of people are surviving and it becomes important to determine and address their long-term and late effects. One of the most prevalent long-term difficulties for both males and females is sexual dysfunction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Horowitz MM. Uses and growth of hematopoietic cell transplantation. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, editors. Thomas’ hematopoietic cell transplantation. New Jersey: Wiley-Blackwell; 2009. p. 15–21.
Syrjala KL, Martin P, Deeg J, Boeckh M. Medical and psychosocial issues in transplant survivors. In: Chang AE, Ganz PA, Hayes DF, Kinsella T, Pass HI, Schiller JH, et al., editors. Oncology: an evidence-based approach. New York, NY: Springer Science + Business Media, Inc.; 2006. p. 1902–28.
Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol. 2005;23(27):6596–606.
Syrjala KL, Kurland BF, Abrams JR, Sanders JE, Heiman JR. Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. Blood. 2008;111(3):989–96.
Syrjala KL, Langer SL, Abrams JR, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA. 2004;291(19):2335–43.
Syrjala KL, Roth-Roemer SL, Abrams JR, et al. Prevalence and predictors of sexual dysfunction in long-term survivors of marrow transplantation. J Clin Oncol. 1998;16(9):3148–57.
Lee SJ, Fairclough D, Parsons SK, et al. Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol. 2001;19(1):242–52.
Yi JC, Syrjala KL. Sexuality after hematopoietic stem cell transplantation. Cancer J. 2009;15(1):57–64.
Syrjala KL, Schroeder TC, Abrams JR, et al. Sexual function measurement and outcomes in cancer survivors and matched controls. J Sex Res. 2000;37(3):213–25.
Andrykowski MA, Bishop MM, Hahn EA, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005;23(3):599–608.
Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM. Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant. 2000;6(5A):576–91.
Zittoun R, Suciu S, Watson M, et al. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation [allogeneic or autologous] or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant. 1997;20(4):307–15.
Chiodi S, Spinelli S, Ravera G, et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol. 2000;110(3):614–9.
Howell SJ, Radford JA, Smets EM, Shalet SM. Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction. Br J Cancer. 2000;82(4):789–93.
Schimmer AD, Ali V, Stewart AK, Imrie K, Keating A. Male sexual function after autologous blood or marrow transplantation. Biol Blood Marrow Transplant. 2001;7(5):279–83.
Wingard JR, Curbow B, Baker F, Zabora J, Paintadosi S. Sexual satisfaction in survivors of bone marrow transplantation. Bone Marrow Transplant. 1992;9:185–90.
Molassiotis A, van den Akker OB, Milligan DW, Boughton BJ. Gonadal function and psychosexual adjustment in male long-term survivors of bone marrow transplantation. Bone Marrow Transplant. 1995;16(2):253–9.
Watson M, Wheatley K, Harrison GA, et al. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer. 1999;86(7):1231–9.
Lof CM, Winiarski J, Giesecke A, Ljungman P, Forinder U. Health-related quality of life in adult survivors after paediatric allo-SCT. Bone Marrow Transplant. 2009;43(6):461–8.
Schover L. Reproductive complications and sexual dysfunction in cancer survivors. In: Ganz P, editor. Cancer survivorship: today and tomorrow. New York: Springer; 2007. p. 251–71.
Claessens JJ, Beerendonk CC, Schattenberg AV. Quality of life, reproduction and sexuality after stem cell transplantation with partially T-cell-depleted grafts and after conditioning with a regimen including total body irradiation. Bone Marrow Transplant. 2006;37(9):831–6.
Humphreys CT, Tallman B, Altmaier EM, Barnette V. Sexual functioning in patients undergoing bone marrow transplantation: a longitudinal study. Bone Marrow Transplant. 2007;39(8):491–6.
Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T. Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplant. 2001;28(5):503–9.
Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav. 1990;19(4):389–408.
Baruch J, Benjamin S, Treleaven J, Wilcox AH, Barron JL, Powles R. Male sexual function following bone marrow transplantation. Bone Marrow Transplant. 1991;7 Suppl 2:52.
Chatterjee R, Kottaridis PD, McGarrigle HH, et al. Patterns of Leydig cell insufficiency in adult males following bone marrow transplantation for haematological malignancies. Bone Marrow Transplant. 2001;28(5):497–502.
Schover LR. Sexuality and fertility after cancer. Hematology. 2005;2005:523–7.
Cust MP, Whitehead MI, Powles R, Hunter M, Milliken S. Consequences and treatment of ovarian failure after total body irradiation for leukemia. Br Med J. 1989;299:1494–7.
Spiryda LB, Laufer MR, Soiffer RJ, Antin JA. Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment. Biol Blood Marrow Transplant. 2003;9(12):760–5.
Winer EP, Lindley C, Hardee M, et al. Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support. Psychooncology. 1999;8(2):167–76.
Duffy C, Allen S. Medical and psychosocial aspects of fertility after cancer. Cancer J. 2009;15(1):27–33.
Schover LR, Schain WS, Montague DK. Sexual problems of patients with cancer. In: DeVita V, Hellman S, Rosenberg SA, editors. Principles and practice of oncology. Philadelphia, PA: J.B. Lippincott; 1989. p. 2206–25.
Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917–31.
Tauchmanova L, Selleri C, Rosa GD, et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer. 2002;95(5):1076–84.
Apperley JF, Reddy N. Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood Rev. 1995;9(2):93–116.
Tierney DK. Sexuality: a quality-of-life issue for cancer survivors. Semin Oncol Nurs. 2008;24(2):71–9.
Green DM, Sklar CA, Boice Jr JD, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2374–81.
Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol. 1988;6(5):813–8.
Monti M, Rosti G, De Giorgi U, et al. Sexual functions after high-dose chemotherapy in survivors of germ cell tumors. Bone Marrow Transplant. 2003;32(9):933–9.
Steffens M, Beauloye V, Brichard B, et al. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL). Clin Endocrinol. 2008;69(5):819–27.
Socie G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003;101(9):3373–85.
Sanders JE, Buckner CD, Leonard JM, Sullivan KM, et al. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation. 1983;36(3):252–5.
Kauppila M, Koskinen P, Irjala K, Remes K, Viikari J. Long-term effects of allogeneic bone marrow transplantation [BMT] on pituitary, gonad, thyroid and adrenal function in adults. Bone Marrow Transplant. 1998;22(4):331–7.
Chatterjee R, Kottaridis PD, McGarrigle HH, Linch DC. Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. Bone Marrow Transplant. 2002;29(7):607–10.
Heaton RK, Grant I, Matthews CG. Comprehensive norms for an expanded Halstead-Reitan battery. Odesa, FL: Psychological Assessment Resources, Inc.; 1992.
Balleari E, Garre S, van Lint MT, et al. Hormone replacement therapy and chronic graft-versus-host disease activity in women treated with bone marrow transplantation for hematologic malignancies. Ann NY Acad Sci. 2002;966:187–92.
Chatterjee R, Kottaridis PD. Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies. Bone Marrow Transplant. 2002;30:629–35.
Shadiack AM, Sharma SD, Earle DC, Spana C, Hallam TJ. Melanocortins in the treatment of male and female sexual dysfunction. Curr Top Med Chem. 2007;7(11):1137–44.
Hayes EC, Rock JA. Treatment of vaginal agglutination associated with chronic graft-versus-host disease. Fertil Steril. 2002;78(5):1125–6.
Spinelli S, Chiodi S, Costantini S, et al. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Haematologica. 2003;88(10):1163–8.
Couriel D, Carpenter PA, Cutler C, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: v. ancillary therapy and supportive care working group report. Biol Blood Marrow Transplant. 2006;12(4):375–96.
Mumma GH, Mashberg D, Lesko LM. Long-term psychosexual adjustment of acute leukemia survivors: impact of marrow transplantation versus conventional chemotherapy. Gen Hosp Psychiatry. 1992;14:43–55.
Hammond C, Abrams JR, Syrjala KL. Fertility and risk factors for elevated infertility concern in 10-year hematopoietic cell transplant survivors and case-matched controls. J Clin Oncol. 2007;25(23):3511–7.
Hawkins Y, Ussher J, Gilbert E, Perz J, Sandoval M, Sundquist K. Changes in sexuality and intimacy after the diagnosis and treatment of cancer: the experience of partners in a sexual relationship with a person with cancer. Cancer Nurs. 2009;32(4):271–80.
Langer SL, Rudd ME, Syrjala KL. Protective buffering and emotional desynchrony among spousal caregivers of cancer patients. Health Psychol. 2007;26(5):635–43.
Tierney DK. Sexuality following hematopoietic cell transplantation. Clin J Oncol Nurs. 2004;8(1):43–7.
Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537–44.
Marks DI, Friedman SH, Carpini LD, Nezu CM, Nezu AM. A prospective study of the effects of high-dose chemotherapy and bone marrow transplantation on sexual function in the first year after transplant. Bone Marrow Transplant. 1997;19:819–22.
Stead ML, Brown JM, Fallowfield L, Selby P. Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues. Br J Cancer. 2003;88(5):666–71.
Vadaparampil S, Quinn G, King L, Wilson C, Nieder M. Barriers to fertility preservation among pediatric oncologists. Patient Educ Couns. 2008;72(3):402–10.
Hordern AJ, Street AF. Communicating about patient sexuality and intimacy after cancer: mismatched expectations and unmet needs. Med J Aust. 2007;186(5):224–7.
Penson RT, Gallagher J, Gioiella ME, et al. Sexuality and cancer: conversation comfort zone. Oncologist. 2000;5(4):336–44.
Corona G, Jannini EA, Maggi M. Inventories for male and female sexual dysfunctions. Int J Impot Res. 2006;18(3):236–50.
Arrington R, Cofrancesco J, Wu AW. Questionnaires to measure sexual quality of life. Qual Life Res. 2004;13(10):1643–58.
Jensen PT, Klee MC, Thranov I, Groenvold M. Validation of a questionnaire for self-assessment of sexual function and vaginal changes after gynaecological cancer. Psychooncology. 2004;13(8):577–92.
Bransfield D, Horiot JC, Nabid A. Development of a scale for assessing sexual function after treatment for gynecologic cancer. J Psychosoc Oncol. 1984;2(1):3–19.
Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899–905.
Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36(7):1002–12.
Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: psychometric evaluation of the brief index of sexual functioning for women. Arch Sex Behav. 1994;23(6):627–43.
Garcia SF, Cella D, Clauser SB, et al. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative (review). J Clin Oncol. 2007;25(32):5106–12.
Jeffery DD, Tzeng JP, Keefe FJ, et al. Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology. Cancer. 2009;115(6):1142–53.
Fortune-Greeley AK, Flynn K, Jeffery D, et al. Using cognitive interviews to evaluate items for measuring sexual functioning across cancer populations: improvements and remaining challenges. Qual Life Res. 2009;18(8):1085–93.
Huyghe E, Sui D, Odensky E, Schover LR. Needs assessment survey to justify establishing a reproductive health clinic at a comprehensive cancer center. J Sex Med. 2009;6(1):149–63.
Park ER, Norris RL, Bober SL. Sexual health communication during cancer care: barriers and recommendations. Cancer J. 2009;15(1):74–7.
Liu J, Malhotra R, Voltarelli J, et al. Ovarian recovery after stem cell transplantation. Bone Marrow Transplant. 2008;41(3):275–8.
Barton DL, Wender DB, Sloan JA, et al. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido. J Natl Cancer Inst. 2007;99(9):672–9.
Kauppila M, Viikari J, Irjala K, Koskinen P, Remes K. The hypothalamus-pituitary-gonad axis and testicular function in male patients after treatment for haematological malignancies. J Intern Med. 1998;244(5):411–6.
Glasgow M, Halfin V, Althausen AF. Sexual response and cancer. CA Cancer J Clin. 1987;37(6):322–33.
Miller DC, Wei JT, Dunn RL, et al. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference. Urology. 2006;68(1):166–71.
Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol. 2008;26(5):753–8.
Masters WH, Johnson VE. Human sexual response. Boston, MA: Little Brown; 1966.
Robinson JW, Faris PD, Scott CB. Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys. 1999;44(3):497–506.
Scott JL, Halford WK, Ward BG. United we stand? The effects of a couple-coping intervention on adjustment to early stage breast or gynecological cancer. J Consult Clin Psychol. 2004;72(6):1122–35.
Rowland JH, Meyerowitz BE, Crespi CM, et al. Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention. Breast Cancer Res Treat. 2009;118(1):99–111.
Acknowledgments
Acknowledgment of Funding Sources: National Cancer Institute grants CA 112631, CA78990, CA 63030 and Lance Armstrong Foundation TE 4198. We thank Allison Stover for her assistance with editing and manuscript preparation.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Yi, J.C., Syrjala, K.L. (2011). Stem Cell Transplant. In: Mulhall, J., Incrocci, L., Goldstein, I., Rosen, R. (eds) Cancer and Sexual Health. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-60761-916-1_36
Download citation
DOI: https://doi.org/10.1007/978-1-60761-916-1_36
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-915-4
Online ISBN: 978-1-60761-916-1
eBook Packages: MedicineMedicine (R0)